STAR SPORTS MED
01609 · HKEXBeijing Tenstar Medical Co.
IPO Timeline
- OpenApr 24
- CloseApr 28
- AllotmentApr 30
- PaymentMay 05
- ListingMay 05
Key Facts
Issue Price
HKD 98.50
Min Entry Fee
HKD 4,974.66
Shares Issued
8.42M
Lot Size
50
Total Raise
HKD 829.5M
Estimated Market Cap
HKD 5.40B
Public Allocation
10.0%
International Placement
90.0%
Business Overview
Beijing Tenstar Medical Co., Ltd. ("Tenstar Medical") is an innovative med-tech enterprise integrating R&D, manufacturing, and commercialization, with a core focus on sports medicine implants, active-powered surgical equipment, consumables, and surgical instruments.
Use of Proceeds
1、Approximately 30.0% (or HK$227.5 million) will be allocated to expanding production capacity and enhancing operational efficiency to meet rapidly growing market demand.
2、Approximately 35.0% (or HK$265.5 million) will be used to support R&D initiatives under our patient-centric product strategy.
3、Approximately 25.0% (or HK$189.6 million) will be deployed for commercialization, sales, and marketing activities to consolidate our leading position in China and establish a global presence and brand image.
4、Approximately 10.0% (or HK$75.8 million) is reserved for working capital and general corporate purposes.
Sponsor Track Record
| Name | Past Deals | First Day Avg % | Break Rate % | 30-Day Avg % |
|---|---|---|---|---|
| 中金香港 | 28 | 12.4 | 21.4 | 8.6 |
| 中信里昂 | 19 | 9.7 | 26.3 | 5.1 |
| 建银国际 | 14 | 6.2 | 35.7 | 1.8 |
Baseline updated: 2026-04-15
Intermediaries & Documents
Sponsors
- 中信证券(香港)有限公司
- CCB International Capital Limited
Underwriters
- CLSA Limited
- CCB International Capital Limited
- China Galaxy International Securities (Hong Kong) Co., Limited
Prospectus PDF
Prospectus PDF →Cornerstone Investors
- JSC International Investment Fund SPC
- 奥博亚洲四期(香港)有限公司
- Mega Prime Development Limited
- Poly Platinum Enterprises Limited
Total
0
34.7% of placement
BBX does not participate in the allocation process for any IPO listed on this page. This page is for informational purposes only and is not investment advice.